It is possible that the small sample sizes and different cancer types may explain the discrepancy between our findings and those of Park et al. Furthermore, studies have used different definitions of cCSCs, which we defined as expressing both CD133 and EpCAM after CD45 depletion. This evidence concerns the gene PTPRC and cancer.